These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27997976)

  • 21. Antibiotics, probiotics and prebiotics in IBD.
    Bernstein CN
    Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics and liver disease.
    Sharma V; Garg S; Aggarwal S
    Perm J; 2013; 17(4):62-7. PubMed ID: 24361022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to modulate gut microbiota: diet, preprobiotics or antibiotics?
    Ponziani FR; Binda C; Gasbarrini A
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):411-419. PubMed ID: 28215066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
    Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
    Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
    Tuohy KM; Fava F; Viola R
    Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the gastrointestinal microbiota in small animal health and disease.
    Redfern A; Suchodolski J; Jergens A
    Vet Rec; 2017 Oct; 181(14):370. PubMed ID: 28916525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre.
    Hart AL; Hendy P
    Proc Nutr Soc; 2014 Nov; 73(4):452-6. PubMed ID: 25221893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiota abnormalities in inflammatory airway diseases - Potential for therapy.
    Gollwitzer ES; Marsland BJ
    Pharmacol Ther; 2014 Jan; 141(1):32-9. PubMed ID: 23969226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?
    Damman CJ; Miller SI; Surawicz CM; Zisman TL
    Am J Gastroenterol; 2012 Oct; 107(10):1452-9. PubMed ID: 23034604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: the future of microbiome-based therapeutics.
    Gulliver EL; Young RB; Chonwerawong M; D'Adamo GL; Thomason T; Widdop JT; Rutten EL; Rossetto Marcelino V; Bryant RV; Costello SP; O'Brien CL; Hold GL; Giles EM; Forster SC
    Aliment Pharmacol Ther; 2022 Jul; 56(2):192-208. PubMed ID: 35611465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead.
    Borody T; Fischer M; Mitchell S; Campbell J
    Expert Rev Gastroenterol Hepatol; 2015; 9(11):1379-91. PubMed ID: 26414076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic treatments and microbes in the gut.
    Macfarlane S
    Environ Microbiol; 2014 Apr; 16(4):919-24. PubMed ID: 24471523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The path towards microbiome-based metabolite treatment.
    Suez J; Elinav E
    Nat Microbiol; 2017 May; 2():17075. PubMed ID: 28540921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BOARD INVITED REVIEW: The pig microbiota and the potential for harnessing the power of the microbiome to improve growth and health1.
    Aluthge ND; Van Sambeek DM; Carney-Hinkle EE; Li YS; Fernando SC; Burkey TE
    J Anim Sci; 2019 Sep; 97(9):3741-3757. PubMed ID: 31250899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiome: Emerging Concepts in Patients with Chronic Liver Disease.
    Reuter B; Bajaj JS
    Clin Liver Dis; 2020 Aug; 24(3):493-520. PubMed ID: 32620285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults.
    Quigley EM
    Nutr Clin Pract; 2012 Apr; 27(2):195-200. PubMed ID: 22127952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of fecal microbiota transplantation suitable for mainstream medicine.
    Khoruts A; Sadowsky MJ; Hamilton MJ
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):246-50. PubMed ID: 25460566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Advanced In Vitro Technology Platform to Study the Mechanism of Action of Prebiotics and Probiotics in the Gastrointestinal Tract.
    Marzorati M; Van de Wiele T
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S124-S125. PubMed ID: 27741154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.